No substrate information.
Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
SLC22A2 |
OCT2 |
Amitriptyline |
11.3 |
|
1-methyl-4-phenylpyridinium (MPP+) |
CHO-OCT2 |
Sandoval, 2018 |
SLC22A1 |
OCT1 |
Amitriptyline |
16.9 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
HEK293-OCT1 |
Ahlin, 2008 |
SLC22A2 |
OCT2 |
Amitriptyline |
1.8 |
|
4-(4-dimethylamino)styryl-N-methylpyridinium (ASP+) |
CHO-OCT2 |
Sandoval, 2018 |
ABCC2 |
MRP2, cMOAT |
Amitriptyline |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC3 |
MRP3 |
Amitriptyline |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC4 |
MRP4 |
Amitriptyline |
>133 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
SLC22A1 |
OCT1 |
Amitriptyline |
6.99 |
|
Metformin |
HEK293-OCT1 |
Ahlin, 2010 |
SLC22A2 |
OCT2 |
Amitriptyline |
0.51 |
|
Metformin |
HEK293-OCT2 |
Hacker, 2015 |
SLC22A2 |
OCT2 |
Amitriptyline |
2.4 |
|
Metformin |
CHO-OCT2 |
Sandoval, 2018 |
SLC22A1 |
OCT1 |
Amitriptyline |
4.4 |
|
Morphine |
HEK293-OCT1 |
Tzvetkov, 2013 |
SLC22A1 |
OCT1 |
Amitriptyline |
1.89 |
|
Morphine |
HEK293-OCT1 |
Zhu, 2018 |
SLC22A2 |
OCT2 |
Amitriptyline |
14 |
|
N-methylpyridinium |
HEK293-OCT2 |
Zolk, 2009 |
SLC22A2 |
OCT2 |
Amitriptyline |
2.5 |
|
NBD-MTMA |
CHO-OCT2 |
Belzer, 2013 |
SLC22A2 |
OCT2 |
Amitriptyline |
4 |
|
NBD-MTMA |
CHO-OCT2 |
Sandoval, 2018 |
SLC22A1 |
OCT1 |
Amitriptyline |
58.1 |
|
Rhodamine 123 |
HEK293-OCT1 |
Jouan, 2014 |
SLC22A1 |
OCT1 |
Amitriptyline |
3.47 |
|
Sumatriptan |
HEK293-OCT1 |
Matthaei, 2016 |
ABCB11 |
BSEP |
Amitriptyline |
>133 |
|
Taurocholate |
Sf9 cell membrane vesicles |
Morgan, 2013 |
SLC22A2 |
OCT2 |
Amitriptyline |
2.4 |
2.5 |
Tetraethylammonium |
S2-OCT2 |
Chiba, 2013 |
SLC22A2 |
OCT2 |
Amitriptyline |
5 |
|
Tetraethylammonium |
CHO-OCT2 |
Sandoval, 2018 |
No drug-drug interaction information.